Navigation Links
Cyprus and Ireland Add Wyeth's 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
Date:9/4/2008

MAIDENHEAD, England, September 4 /PRNewswire-FirstCall/ --

- Prevenar Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Worldwide

Wyeth today announced that Cyprus and the Republic of Ireland have initiated national immunisation programmes (NIPs) for infants and young children against pneumococcal disease by adding Prevenar(TM) (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed), also called PCV7, to their national immunization schedules.(1) Including Ireland and Cyprus, this now makes 26 countries across the world that have included Prevenar in their NIPs.(1)

"Wyeth, the manufacturer of Prevenar, is pleased to be part of these initiatives and welcomes the introduction of this life-saving vaccine into national immunization schedules," says Dr E. David McIntosh, a paediatrician and European Medical Director, Infectious Diseases/Vaccines at Wyeth. "Wyeth is dedicated to the wellbeing of children and to continuing to work with governments and public health agencies to further expand access to Prevenar to help prevent serious and debilitating pneumococcal infections caused by serotypes contained in the vaccine. This includes facilitating the introduction of the vaccine in those countries that have announced their decision to include Prevenar in their national immunisation programmes but have yet to introduce the vaccine as part of their immunisation schedule."

Pneumococcal disease results in approximately 1.6 million deaths per year worldwide of which up to 1 million deaths are in children younger than five years of age.(2) Pneumococcal disease is the leading vaccine-preventable cause of death in children younger than five years of age worldwide.(3)

The World Health Organization (WHO) recommends priority inclusion of the 7-valent pneumococcal conjugate vaccine in national childhood immunization programs worldwide due to the significant burden of pneumococcal disease and
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SAFC Supports Potent API Conjugate Manufacturing With New St. Louis Production Suite
2. Global Experts Explore Entire Spectrum of Aids Vaccine Development
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
5. Anthrax vaccine produces immunity with nanoparticles, not needles
6. FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox
7. International Scientific Workshop Focuses on New Methods for Vaccine and Antibody Development
8. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
9. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
10. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
11. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 Gene synthesis and ... has entered into a technology access and services ... apply DNA2.0’s proprietary protein engineering technology, known as ... “We are extremely excited that the global leader ... This proprietary bioengineering technology has now been validated ...
(Date:12/17/2014)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytic ... next step in its expanded strategy to rebuild the ... naming of current Chief Operating Officer, Valerie Palmieri ... Chairman of the Board and CEO James LaFrance ... are effective January 1, 2015. "Jim and ...
(Date:12/17/2014)... 17, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a primary commercial focus on China ... a Type C meeting with the U.S. Food and ... held in February 2015.  During this meeting the Company ...
(Date:12/17/2014)... 2014   Synageva BioPharma Corp. (NASDAQ: ... for rare disorders, announced today its presentation at the ... San Francisco, CA. ... will present on Monday, January 12, 2015, at 9:00 ... webcast live and may be accessed from the "Webcasts ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... The Center for Molecular Biology,(CMB) has received an ... Gates,Foundation to support continued development of an avian ... develop vaccines against,highly pathogenic avian influenza viruses of ... clinical trials. , Dr. ...
... ArunA Biomedical, Inc., announced today that it will make ... in early 2009. The cells, derived from NIH ... normal, consistent population of neural cells in an adherent ... research community. hN2 cells provide a human cell ...
... EUCODIS Bioscience, a company,developing enzymes for the chemical industry, ... Chief Financial Officer. , "We ... brings to,EUCODIS Bioscience," said Rudy Pandjaitan, Ph.D., CEO of ... and his close relations,with the investment community will be ...
Cached Biology Technology:Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development 2ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells 2EUCODIS Bioscience Appoints Thomas Fischer as Chief Financial Officer 2
(Date:12/17/2014)... BELVOIR, Va. , Dec. 15, 2014 /PRNewswire-USNewswire/ ... efforts to make it easier to detect and ... chain. Today the agency started performing ... The capability will validate the authenticity of purchased ... chain. The new quality control measures will be ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
(Date:12/10/2014)... , Dec. 8, 2014 You,ve been here ... account but can,t remember your password, site key or the ... was your first grade teacher? Today, ... the app that will finally put an end to ... 1U TM . 1U leverages a user,s smartphone ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... While hunting among chimpanzees is a group effort, key ... group. They are more likely to initiate a hunt, and ... study. The findings, which appear in the current issue ... animals cooperate to hunt for food, and how individual variation ...
... Ind. - Purdue University and USDA-Agricultural Research Service scientists ... plants halts infection by a disease-causing fungus that can ... research team is the first to show that the ... grasses - from the devastating, fungal pathogen. The naturally ...
... from an innovative computational approach could speed up the ... development, researchers from the University of Chicago Medical Center ... published in the February 2008 issue of Genome Research, ... of the human genes and proteins that serve as ...
Cached Biology News:Key 'impact hunters' catalyze hunting among male chimpanzees 2Key 'impact hunters' catalyze hunting among male chimpanzees 3Gene guards grain-producing grasses so people and animals can eat 2Gene guards grain-producing grasses so people and animals can eat 3Study of successful drug targets could hasten development of new medications 2Study of successful drug targets could hasten development of new medications 3
45° Fixed Angle Rotor for use in the IEC Centra CL2, Centra CL3/CL3R, HN-SII, and the Centra-MP4/MP4R....
... The Lambda 10-2 is a microprocessor ... impressive speed coupled with exceptionally smooth ... for research applications involving fluorescence microscopy, ... any application requiring rapid and accurate ...
... FL is equipped with ... measurement technologies that complement ... advanced features of Fluoroskan ... Fluoroskan Ascent FL provides ...
... an enzyme that catalyzes the hydrolysis ... maltotriose, and dextrins. The,level of a-amylase ... body is of,clinical significance in the ... diabetes; plant and microbial a-amylases are,important ...
Biology Products: